Shoaibi, Azza

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology

Rheumatoid Arthritis Research and TherapiesPharmacovigilance and Adverse Drug Reactions

Cited by 258

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P. R., et al. (2021) · BMJ

Pharmacovigilance and Adverse Drug ReactionsSARS-CoV-2 and COVID-19 Research

Cited by 219

A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries

Mason, H., Shoaibi, A., Ghandour, R., O'Flaherty, M., Capewell, S., Khatib, R., Jabr, S., Unal, B., Sözmen, K., Arfa, C., et al. (2014) · PLoS ONE

Sodium Intake and HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 110

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Cai, C. X., Nishimura, A., Bowring, M. G., Westlund, E., Tran, D., Ng, J. H., Nagy, P., Cook, M., McLeggon, J.-A., DuVall, S. L., et al. (2024) · Ophthalmology Retina

Retinal Diseases and TreatmentsDrug-Induced Ocular Toxicity

Cited by 20